WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001036602) PAK5 A MEMBER OF THE P21-ACTIVATED KINASE (PAK) PROTEIN FAMILY, NUCLEIC ACIDS AND METHODS RELATED TO THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/036602 International Application No.: PCT/EP2000/010736
Publication Date: 25.05.2001 International Filing Date: 14.11.2000
Chapter 2 Demand Filed: 30.05.2001
IPC:
A61K 39/00 (2006.01) ,C12N 9/12 (2006.01)
Applicants: DAHLBERG, Mats[SE/SE]; SE (UsOnly)
MOLL, Jurgen[DE/IT]; IT (UsOnly)
GALVANI, Arturo[IT/IT]; IT (UsOnly)
PHARMACIA ITALIA S.P.A.[IT/IT]; Via Robert Koch, 1.2 I-20152 Milano, IT (AllExceptUS)
Inventors: DAHLBERG, Mats; SE
MOLL, Jurgen; IT
GALVANI, Arturo; IT
Agent: PHARMACIA & UPJOHN S.P.A.; Patent Department Viale Pasteur, 10 I-20014 Nerviano, IT
Priority Data:
09/439,75615.11.1999US
Title (EN) PAK5 A MEMBER OF THE P21-ACTIVATED KINASE (PAK) PROTEIN FAMILY, NUCLEIC ACIDS AND METHODS RELATED TO THE SAME
(FR) NOUVEAU MEMBRE DE LA FAMILLE DES PROTEINES PAK, DES ACIDES NUCLEIQUES ET PROCEDES CORRESPONDANTS
Abstract:
(EN) The present invention provides a human polypeptide homolog of P21-activated kinase (PAK) polynucleotides which identify and encode PAK5 serine/threonine kinase. In addition, the inventon provides expression vectors, host cells and methods for its production. The invention also provides methods for the identification of PAK5 agonists/antagonists, useful for the treatment of human diseases and conditions.
(FR) La présente invention concerne un homologue polypeptide humain de polynucléotides PAK5 qui identifie et code la kinase sérine/thréonine PAK5. L'invention concerne également des vecteurs d'expression, des cellules hôtes et leurs procédés de production, ainsi que des procédés d'identification d'agonistes/antagonistes PAK5 utiles dans le traitement des maladies et des états pathologiques de l'homme.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)